Frailty in end-stage renal disease: comparing patient, caregiver, and clinician perspectives

David A Clark, Usman Khan, Bryce A Kiberd, Colin C Turner, Alison Dixon, David Landry, Heather C Moffatt, Paige A Moorhouse, Karthik K Tennankore, David A Clark, Usman Khan, Bryce A Kiberd, Colin C Turner, Alison Dixon, David Landry, Heather C Moffatt, Paige A Moorhouse, Karthik K Tennankore

Abstract

Background: Frailty is associated with poor outcomes for patients on dialysis and is traditionally measured using tools that assess physical impairment. Alternate measurement tools highlight cognitive and functional domains, requiring clinician, patient, and/or caregiver input. In this study, we compared frailty measures for incident dialysis patients that incorporate patient, clinician, and caregiver perspectives with an aim to contrast the measured prevalence of frailty using tools derived from different conceptual frameworks.

Methods: A prospective cohort study of incident dialysis patients was conducted between February 2014 and June 2015. Frailty was assessed at dialysis onset using: 1) modified definition of Fried Phenotype (Dialysis Morbidity Mortality Study definition, DMMS); 2) Clinical Frailty Scale (CFS); 3) Frailty Assessment Care Planning Tool (provides CFS grading, FACT-CFS); and 4) Frailty Index (FI). Measures were compared via correlation and sensitivity/specificity analyses.

Results: A total of 98 patients participated (mean age of 61 ± 14 years). Participants were primarily Caucasian (91%), male (58%), and the majority started on hemodialysis (83%). The median score for both the CFS and FACT-CFS was 4 (interquartile range of 3-5). The mean FI score was 0.31 (standard deviation ± 0.16). The DMMS identified 78% of patients as frail. The FACT-CFS demonstrated highest correlation (r = 0.71) with the FI, while the DMMS was most sensitive (97%, 100%) and a CFS ≥ 5 most specific (100%, 77%) at corresponding FI cutoff values (>0.21, >0.45).

Conclusions: Frailty assessments of incident dialysis patients that include clinician, caregiver and patient perspectives have moderate to strong correlation with the FI. At specified FI cutoff values, the FACT-CFS and DMMS are highly sensitive measures of frailty. The CFS and FACT-CFS may represent viable alternative screening tools in dialysis patients.

Keywords: Clinical frailty scale; Dialysis; Frailty; Frailty index; Fried phenotype.

Figures

Fig. 1
Fig. 1
Cohort Selection
Fig. 2
Fig. 2
Distribution of CFS and FACT-CFS scores. CFS, Clinical Frailty Scale. FACT, Frailty Assessment for Care-Planning Tool

References

    1. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–156. doi: 10.1093/gerona/56.3.M146.
    1. Mitnitski AB, Mogilner AJ, Rockwood K. Accumulation of deficits as a proxy measure of aging. ScientificWorldJournal. 2001;1:323–336. doi: 10.1100/tsw.2001.58.
    1. Alfaadhel TA, Soroka SD, Kiberd BA, Landry D, Moorhouse P, Tennankore KK. Frailty and mortality in dialysis: evaluation of a clinical frailty scale. Clin J Am Soc Nephrol. 2015;10(5):832–840. doi: 10.2215/CJN.07760814.
    1. Bao Y, Dalrymple L, Chertow GM, Kaysen GA, Johansen KL. Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med. 2012;172(14):1071–1077. doi: 10.1001/archinternmed.2012.3020.
    1. Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960–2967. doi: 10.1681/ASN.2007020221.
    1. McAdams-DeMarco MA, Law A, Salter ML, Boyarsky B, Gimenez L, Jaar BG, Walston JD, Segev DL. Frailty as a novel predictor of mortality and hospitalization in individuals of all ages undergoing hemodialysis. J Am Geriatr Soc. 2013;61(6):896–901. doi: 10.1111/jgs.12266.
    1. McAdams-DeMarco MA, Suresh S, Law A, Salter ML, Gimenez LF, Jaar BG, Walston JD, Segev DL. Frailty and falls among adult patients undergoing chronic hemodialysis: a prospective cohort study. BMC Nephrol. 2013;14:224. doi: 10.1186/1471-2369-14-224.
    1. Bouillon K, Kivimaki M, Hamer M, Sabia S, Fransson EI, Singh-Manoux A, Gale CR, Batty GD. Measures of frailty in population-based studies: an overview. BMC Geriatr. 2013;13:64. doi: 10.1186/1471-2318-13-64.
    1. Hubbard RE, Peel NM, Smith M, Dawson B, Lambat Z, Bak M, Best J, Johnson DW. Feasibility and construct validity of a Frailty index for patients with chronic kidney disease. Australas J Ageing. 2015;34(3):E9–12. doi: 10.1111/ajag.12231.
    1. Chao CT, Hsu YH, Chang PY, He YT, Ueng RS, Lai CF, Chiang CK, Huang JW, Huang SJ. Simple self-report FRAIL scale might be more closely associated with dialysis complications than other frailty screening instruments in rural chronic dialysis patients. Nephrology (Carlton, Vic) 2015;20(5):321–328. doi: 10.1111/nep.12401.
    1. Moorhouse P, Rockwood K. Frailty and its quantitative clinical evaluation. J R Coll Physicians Edinb. 2012;42(4):333–340. doi: 10.4997/JRCPE.2012.412.
    1. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–495. doi: 10.1503/cmaj.050051.
    1. Mallery LH, Allen M, Fleming I, Kelly K, Bowles S, Duncan J, Moorhouse P. Promoting higher blood pressure targets for frail older adults: a consensus guideline from Canada. Cleve Clin J Med. 2014;81(7):427–437. doi: 10.3949/ccjm.81a.13110.
    1. Boron S, Scanlan J, Brush M, Vitaliano P, Dokmak A. The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000;15(11):1021–1027. doi: 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>;2-6.
    1. Reisberg B, Ferris SH. Brief Cognitive Rating Sale (BCRS) Psychopharmacol Bull. 1988;24(4):629–636.
    1. Searle SD, Mitnitski A, Gahbauer EA, Gill TM, Rockwood K. A standard procedure for creating a frailty index. BMC Geriatr. 2008;8:24. doi: 10.1186/1471-2318-8-24.
    1. van Munster BC, Drost D, Kalf A, Vogtlander NP. Discriminative value of frailty screening instruments in end-stage renal disease. Clin Kidney J. 2016;9(4):606–610. doi: 10.1093/ckj/sfw061.
    1. Blodgett J, Theou O, Kirkland S, Andreou P, Rockwood K. Frailty in NHANES: Comparing the frailty index and phenotype. Arch Gerontol Geriatr. 2015;60(3):464–470. doi: 10.1016/j.archger.2015.01.016.
    1. Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM. Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2014;64(4):600–607. doi: 10.1053/j.ajkd.2014.03.016.
    1. Painter P, Kuskowski M. A closer look at frailty in ESRD: getting the measure right. Hemodial Int. 2013;17(1):41–49. doi: 10.1111/j.1542-4758.2012.00719.x.
    1. Rockwood K, Theou O, Mitnitski A. What are frailty instruments for? Age Ageing. 2015;44(4):545–7. doi: 10.1093/ageing/afv043.
    1. Johansen KL, Dalrymple LS, Delgado C, Kaysen GA, Kornak J, Grimes B, Chertow GM. Association between body composition and frailty among prevalent hemodialysis patients: a US Renal Data System special study. J Am Soc Nephrol. 2014;25(2):381–389. doi: 10.1681/ASN.2013040431.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe